摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-Butyryl-4-(2-hydroxyanilino)-6-methyl-2H-pyran-2-one

中文名称
——
中文别名
——
英文名称
3-Butyryl-4-(2-hydroxyanilino)-6-methyl-2H-pyran-2-one
英文别名
3-butanoyl-4-(2-hydroxyanilino)-6-methylpyran-2-one
3-Butyryl-4-(2-hydroxyanilino)-6-methyl-2H-pyran-2-one化学式
CAS
——
化学式
C16H17NO4
mdl
MFCD05859684
分子量
287.31
InChiKey
ZDIYJQMKVQXCKZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    21
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    75.6
  • 氢给体数:
    2
  • 氢受体数:
    5

文献信息

  • [EN] ADMINISTRATION OF CALCIUM CHANNEL TRPC6 INHIBITORS USING BALLOONS, STENTS OR OTHER MEDICAL DEVICES<br/>[FR] ADMINISTRATION D'INHIBITEURS CALCIQUE TRPC6 À L'AIDE DE BALLONNETS, D'ENDOPROTHÈSES OU D'AUTRES DISPOSITIFS MÉDICAUX
    申请人:KLINIKUM RECHTS DER ISAR
    公开号:WO2021160625A1
    公开(公告)日:2021-08-19
    The present invention relates to a medical device suitable for being inserted into the lumen of an anatomic structure of a subject, said medical device comprising means for administration of TRPC6 inhibitor, wherein said means comprises the TRPC6 inhibitor. The present invention further concerns a method of manufacturing a medical device suitable for being inserted into the lumen of an anatomic structure of a subject. Also, the invention relates to a TRPC6 inhibitor for use in the treatment or prevention of a disease associated with neointimal hyperplasia associated with the migration of smooth muscular cells. The invention also relates to a method of treating or preventing a disease associated with neointimal hyperplasia, said method comprising administering a TRPC6 inhibitor to a subject in need thereof. Also envisaged is a method of inhibiting migration of smooth muscle cells. The invention additionally relates to an in vitro test kit comprising: (a) small muscle cells (SMCs); (b) a surface suitable for SMC cultivation coated with a TRPC6 inhibitor. Also concerned is a pharmaceutical composition comprising a TRPC6 inhibitor and a pharmaceutically acceptable carrier.
查看更多